Persistence of viral infection despite similar killing efficacy of antiviral CD8+ T cells during acute and chronic phases of infection

Virology

Volumn 405, Issue 1, 2010, Pages 193-200

  Ganusov, Vitaly V ^a,d   Lukacher, Aron E ^b   Byers, Anthony M ^c  

^a UNIVERSITY OF TENNESSEE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VaxDesign Inc   (United States)

^d LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

CD8 T cell response; Chronic infection; In vivo cytotoxicity; Killing efficacy; Mathematical models; Polyoma virus

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; EFFECTOR CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; POLYOMA VIRUS; PRIORITY JOURNAL;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS; POLYOMAVIRUS;

EID: 77955514164     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.05.029     Document Type: Article

References (53)

1. Abend J.R., Low J.A., Imperiale M.J. Inhibitory effect of gamma interferon on BK virus gene expression and replication. J. Virol. 2007, 81:272-279.
2. Agnellini P., Wolint P., Rehr M., Cahenzli J., Karrer U., Oxenius A. Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4565-4570.
3. Aichele P., Brduscha-Riem K., Oehen S., Odermatt B., Zinkernagel R., Hengartner H., Pircher H. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 1997, 6:519-529.
4. Althaus C., Ganusov V., De Boer R. Dynamics of CD8+ T cell responses during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 2007, 179:2944-2951.
5. Antia R., Ganusov V., Ahmed R. The role of models in understanding CD8+ T-cell memory. Nat. Rev. Immunol. 2005, 5:101-111.
6. Badovinac V., Porter B., Harty J. Programmed contraction of CD8(+) T cells after infection. Nat. Immunol. 2002, 3:619-626.
7. Barber D., Wherry E., Ahmed R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 2003, 171:27-31.
8. Barchet W., Oehen S., Klenerman P., Wodarz D., Bocharov G., Lloyd A.L., Nowak M.A., Hengartner H., Zinkernagel R.M., Ehl S. Direct quantitation of rapid elimination of viral antigen-positive lymphocytes by antiviral CD8(+) T cells in vivo. Eur. J. Immunol. 2000, 30:1356-1363.
9. Bates D.M., Watts D.G. Nonlinear Regression Analysis and its Applications 1988, John Wiles & Sons, Inc.
10. Blattman J.N., Antia R., Sourdive D.J., Wang X., Kaech S.M., Murali-Krishna K., Altman J.D., Ahmed R. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 2002, 195:657-664.
11. Brooks D., Trifilo M., Edelmann K., Teyton L., McGavern D., Oldstone M. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006, 12:1301-1309.
12. Burnham K.P., Anderson D.R. Model Selection and Multimodel Inference: a Practical Information-Theoretic Approach 2002, Springer-Verlag, New York.
13. Byers A., Kemball C., Moser J., Lukacher A. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J. Immunol. 2003, 171:17-21.
14. Byers A.M., Hadley A., Lukacher A.E. Protection against polyoma virus-induced tumors is perforin-independent. Virology 2007, 358:485-492.
15. Cush S.S., Flano E. Protective antigen-independent CD8 T cell memory is maintained during {gamma}-herpesvirus persistence. J. Immunol. 2009, 182:3995-4004.
16. Cush S.S., Anderson K.M., Ravneberg D.H., Weslow-Schmidt J.L., Flano E. Memory generation and maintenance of CD8+ T cell function during viral persistence. J. Immunol. 2007, 179:141-153.
17. De Boer R.J., Oprea M., Antia R., Murali-Krishna K., Ahmed R., Perelson A.S. Recruitment times, proliferation, and apoptosis rates during the CD8(+) T-cell response to lymphocytic choriomeningitis virus. J. Virol. 2001, 75:10663-10669.
18. De Boer R., Homann D., Perelson A. Different dynamics of CD4(+) and CD8(+) T cell responses during and after acute lymphocytic choriomeningitis virus infection. J. Immunol. 2003, 171:3928-3935.
19. Efron B., Tibshirani R. An Introduction to the Bootstrap 1993, Chapman & Hall, New York.
20. Ejrnaes M., Filippi C., Martinic M., Ling E., Togher L., Crotty S., von Herrath M. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 2006, 203:2461-2472.
21. Frohlich A., Kisielow J., Schmitz I., Freigang S., Shamshiev A.T., Weber J., Marsland B.J., Oxenius A., Kopf M. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 2009, 324:1576-1580.
22. Fuller M., Khanolkar A., Tebo A., Zajac A. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J. Immunol. 2004, 172:4204-4214.
23. Ganusov V., De Boer R. Estimating costs and benefits of CTL escape mutations in SIV/HIV infection. PLoS Comput. Biol. 2006, 2:e24.
24. Ganusov V.V., De Boer R.J. Estimating in vivo death rates of targets due to CD8 T-cell-mediated killing. J. Virol. 2008, 82:11749-11757.
25. Ganusov V., Milutinovic D., De Boer R. IL-2 regulates expansion of CD4+ T cell populations by affecting cell death: insights from modeling CFSE data. J. Immunol. 2007, 179:950-957.
26. Grossman Z., Paul W. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:10365-10369.
27. Grossman Z., Singer A. Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:14747-14752.
28. Ingulli E. Tracing tolerance and immunity in vivo by CFSE-labeling of administered cells. Methods Mol. Biol. 2007, 380:365-376.
29. Kaech S.M., Ahmed R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2001, 2:415-422.
30. Kaech S.M., Wherry E.J., Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2002, 2:251-262.
31. Kemball C.C., Lee E.D., Vezys V., Pearson T.C., Larsen C.P., Lukacher A.E. Late priming and variability of epitope-specific CD8+ T cell responses during a persistent virus infection. J. Immunol. 2005, 174:7950-7960.
32. Krumbholz A., Bininda-Emonds O.R., Wutzler P., Zell R. Phylogenetics, evolution, and medical importance of polyomaviruses. Infect. Genet. Evol. 2009, 9:784-799.
33. Lau L., Jamieson B., Somasundaram T., Ahmed R. Cytotoxic T-cell memory without antigen. Nature 1994, 369:648-652.
34. Li Q., Skinner P.J., Ha S.J., Duan L., Mattila T.L., Hage A., White C., Barber D.L., O'Mara L., Southern P.J., Reilly C.S., Carlis J.V., Miller C.J., Ahmed R., Haase A.T. Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 2009, 323:1726-1729.
35. Lukacher A., Moser J., Hadley A., Altman J. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection. J. Immunol. 1999, 163:3369-3378.
36. Maris C., Chappell C., Jacob J. Interleukin-10 plays an early role in generating virus-specific T cell anergy. BMC Immunol. 2007, 8:8.
37. Mempel T., Junt T., von Andrian U. Rulers over randomness: stroma cells guide lymphocyte migration in lymph nodes. Immunity 2006, 25:867-869.
38. Miller N., Bonczyk J., Nakayama Y., Suresh M. Role of thymic output in regulating CD8 T-cell homeostasis during acute and chronic viral infection. J. Virol. 2005, 79:9419-9429.
39. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.E., Layden T.J., Perelson A.S. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998, 282:103-107.
40. Obar J.J., Fuse S., Leung E.K., Bellfy S.C., Usherwood E.J. Gammaherpesvirus persistence alters key CD8 T-cell memory characteristics and enhances antiviral protection. J. Virol. 2006, 80:8303-8315.
41. Oehen S., Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 1998, 161:5338-5346.
42. Perelson A., Neumann A., Markowitz M., Leonard J., Ho D. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 1996, 271:1582-1586.
43. Regoes R., Barber D., Ahmed R., Antia R. Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1599-1603.
44. Rowland-Jones S., de Silva T. Resisting immune exhaustion in HIV-1 infection. PLoS Med. 2008, 5:e103.
45. Slifka M.K., Whitton J.L. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat. Immunol. 2001, 2:711-717.
46. Streeck H., Brumme Z.L., Anastario M., Cohen K.W., Jolin J.S., Meier A., Brumme C.J., Rosenberg E.S., Alter G., Allen T.M., Walker B.D., Altfeld M. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med. 2008, 5:e100.
47. Vezys V., Masopust D., Kemball C., Barber D., O'Mara L., Larsen C., Pearson T., Ahmed R., Lukacher A. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 2006, 203:2263-2269.
48. Wherry E., Ahmed R. Memory CD8 T-cell differentiation during viral infection. J. Virol. 2004, 78:5535-5545.
49. Wherry E., Blattman J., Murali-Krishna K., Van Der Most R., Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 2003, 77:4911-4927.
50. Wherry E.J., Ha S.J., Kaech S.M., Haining W.N., Sarkar S., Kalia V., Subramaniam S., Blattman J.N., Barber D.L., Ahmed R. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007, 27:670-684.
51. Yates A., Graw F., Barber D.L., Ahmed R., Regoes R.R., Antia R. Revisiting estimates of CTL killing rates in vivo. PLoS ONE 2007, 2:e1301.
52. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J., Suresh M., Altman J.D., Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 1998, 188:2205-2213.
53. Zehn D., Lee S.Y., Bevan M.J. Complete but curtailed T-cell response to very low-affinity antigen. Nature 2009, 458:211-214.